Beginning February 13, 2026, was the start of 121 days when astrazenecagrouptrials.pharmacm.com passed 1 accessibility tests. According to the total tests made, astrazenecagrouptrials.pharmacm.com was up 1 times, most recent February 13, 2026, returning a 200 status code. Astrazenecagrouptrials.pharmacm.com did not face any periods of unavailability based on all inspections made as of June 15, 2026. The error-free status has been reported for all responses received as of June 15, 2026. On February 13, 2026, astrazenecagrouptrials.pharmacm.com had a recorded response time of 0.001 seconds and an average response time of 0.001 seconds.
Discover AstraZeneca Clinical Trials and Research Studies | astrazenecaclinicaltrials.com
Description
This site is part of AstraZeneca`s commitment to provide patients, their relatives, caregivers, doctors, researchers and the public with information about AstraZeneca clinical trials, which includes trials sponsored by a member of the AstraZeneca Group of Companies. This site has been developed to increase knowledge and awareness around what clinical trials are and what it means to participate in a clinical trial.